Market Research Logo

Finland Pharmaceuticals and Healthcare Report Q2 2016

Finland Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Finland's healthcare system has suffered from a lack of cooperation between primaryhealthcare and specialised medical care in recent years. Although the Finnish healthcare system isundergoing reforms, it will be a while before such changes have an impact, especially considering the weakstate of the economy. In the long term, an aging population and high per capita spending will drive demandfor high-value medicines and quality medical services. However, we believe the associated rising costs willkeep the healthcare and pharmaceutical sectors a target for government cost-containment measures.

Headline Expenditure Projections

Pharmaceuticals: EUR2.94bn (USD3.23bn) in 2015 to EUR3.03bn (USD3.24bn) in 2016;+3.1% inlocal currency terms and +0.3% in US dollar terms. Forecast unchanged from last quarter.

Healthcare: EUR19.63bn (USD21.59bn) in 2015 to EUR20.42bn (USD21.85bn) in 2016; +4.0% in localcurrency terms and +1.2% in US dollar terms. Forecast unchanged from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Finland 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Finland 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2014-2020)
Industry Risk/Reward Index
Western Europe Risk/Reward Index
Finland Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Finland 2010-2015)
Table: Healthcare Personnel (Finland 2010-2015)
Table: Healthcare Activity (Finland 2010-2015)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Table: PIF Members
Pharmaceutical Distribution & Retail Sector
Demographic Forecast
Table: Population Headline Indicators (Finland 1990-2025)
Table: Key Population Ratios (Finland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Finland 1990-2025)
Table: Population By Age Group (Finland 1990-2025)
Table: Population By Age Group % (Finland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report